AlphaFold predicted structure
PTPN13 · Q12923

Mean pLDDT
60.0/ 100
Low
2,485 residues
Confidence breakdown
- Very high(≥ 90)20%
- Confident(70–90)28%
- Low(50–70)6%
- Very low(< 50)46%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
protein tyrosine phosphatase non-receptor type 13
Annotations refreshed 9 hours ago.
Moderate Evidence (Amber)
Haematological malignancies cancer susceptibility
BIALLELIC, autosomal or pseudoautosomalpancreatic ductal adenocarcinoma
gastric carcinoma
endometrial endometrioid adenocarcinoma
ovarian endometrioid adenocarcinoma with squamous differentiation
kidney neoplasm
Transitional Meningioma
skin basal cell carcinoma
hemangioblastoma
carcinoma of liver and intrahepatic biliary tract
Atypical Meningioma
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
Tyrosine-protein phosphatase non-receptor type 13
Tyrosine phosphatase which negatively regulates FAS-induced apoptosis and NGFR-mediated pro-apoptotic signaling (PubMed:15611135). May regulate phosphoinositide 3-kinase (PI3K) signaling through dephosphorylation of PIK3R2 (PubMed:23604317)
PTPN13 · Q12923

Mean pLDDT
60.0/ 100
Low
2,485 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0